483 AstraZeneca Pharmaceuticals, LP Aug 2017

483 AstraZeneca Pharmaceuticals, LP Aug 2017

Anita Michael FDA, Michael Taylor FDA$119.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals, LP - Newark, DE, United States facility and issued inspectional observations (via FDA 483) on 24 Aug 2017.

Product details

  • Category: Foods & Cosmetics / Human Drugs
  • Inspection end: 24 Aug 2017
  • Location: Newark, United States
  • FEI: 2517100
Add To Cart